Stryker Corporation experienced downward pressure accompanied by heightened intraday volatility as market participants engaged in profit-taking following a short-lived bounce driven by government contract news. While the company recently secured a multi-year contract modification with the U.S. Defense Logistics Agency, the initial positive momentum faded as broader institutional focus reverted back to underlying operational headwinds and sector-wide valuation reassessments. The pullback reflects ongoing market debate over whether recent short-term catalysts are sufficient to overcome broader performance lagging compared to major equity benchmarks and medical device peers.

From a fundamental perspective, Stryker continues to navigate a…